Related Experiment Video
Updated: Sep 11, 2025

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
Published on: March 24, 2023
The Changing Spectrum of Pediatric Allergic Contact Dermatitis: A Prospective Multicentric Study in Spain
Nidia Planella-Fontanillas1,2, David Pesqué1,3, Leopoldo Borrego4
1From the, Department of Dermatology, Hospital del Mar Research Institute, Barcelona, Spain.
Insights
Allergic contact dermatitis (ACD) affects children, with patch testing revealing high sensitization rates. Emerging allergens like linalool and limonene hydroperoxides require attention for better pediatric ACD management.
Area of Science:
- Dermatology
- Pediatrics
- Allergology
Background:
- Allergic contact dermatitis (ACD) prevalence is rising in children, showing age-related differences.
- Understanding these patterns is crucial for effective diagnosis and management.
- Pediatric ACD requires updated clinical and epidemiological data.
Purpose of the Study:
- To update clinical and epidemiological characteristics of pediatric ACD.
- To determine sensitization frequencies and the relevance of positive patch tests.
- To analyze age-specific variations in pediatric ACD.
Main Methods:
- Prospective multicenter study of pediatric patients (0-16 years) using the REIDAC registry.
- Stratification into two age groups: 0-5 years and 6-16 years.
- Patch testing conducted with GEIDAC baseline and extended series (Jan 2019 - Dec 2023).
Main Results:
- 508 children underwent patch testing; 179 (35.2%) were sensitized.
- In 0-5 years group (n=41), 24.4% sensitized; face and hands most affected. Linalool and limonene hydroperoxides were top allergens.
- In 6-16 years group (n=467), 36.2% sensitized; face and hands most affected. Linalool hydroperoxide and methylisothiazolinone were top allergens.
Conclusions:
- High sensitization rates in both pediatric age groups underscore the importance of patch testing.
- Linalool and limonene hydroperoxides are identified as significant emerging sensitizers.
- Age-specific management strategies are essential for improving pediatric ACD outcomes.
Abstract:
Background: Allergic contact dermatitis (ACD) is increasingly common in children, with age-related variations suggesting changing exposure patterns.Objective: Updating clinical and epidemiological characteristics, sensitization frequency, and relevance of positive patch tests in pediatric patients.Methods: This prospective multicenter study analyzed data from the Spanish Contact Dermatitis Research Group registry (REIDAC) for patients aged 0-16 years, stratified into 2 groups: 0-5 and 6-16 years. Participants were patch tested with the GEIDAC baseline and extended series from January 2019 to December 2023.Results: Patch tests were performed on 508 children, of whom 179 (35.2%) were sensitized. Among children aged 0-5 years (n = 41), 10 (24.4%) had positive patch tests, with lesions predominantly affecting the face (51.2%), hands (17.0%), and legs (4.9%). Atopic dermatitis (AD) was present in 36.6%, with linalool and limonene hydroperoxides as top sensitizers. In the 6-16 years group (n = 467), 169 patients (36.2%) were sensitized. AD was present in 45.0%, with lesions involving the face (24.0%), hands (23%), and legs (7.0%). Top allergens were linalool hydroperoxide and methylisothiazolinone.Conclusions: High sensitization proportions in both age groups highlight the importance of patch testing. Hydroperoxides of linalool and limonene are emerging as key sensitizers. Age-specific considerations may improve pediatric ACD management.
Related Concept Videos
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Allergic Reactions
Allergic Drug Reactions
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

